home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9605a.zip
/
M9650221.TXT
< prev
next >
Wrap
Text File
|
1996-03-09
|
2KB
|
31 lines
Document 0221
DOCN M9650221
TI Prevalence of hepatitis C in patients with primary antibody deficiency.
DT 9605
AU Webster AD; Brown D; Franz A; Dusheiko G; Department of Clinical
Immunology, Royal Free Hospital, London,; UK.
SO Clin Exp Immunol. 1996 Jan;103(1):5-7. Unique Identifier : AIDSLINE
MED/96150273
AB Concern over sporadic hepatitis C virus (HCV) infection from treatment
with contaminated immunoglobulin in patients with immunodeficiency
prompted use to screen serum from 44 patients for HCV RNA. We found no
evidence of either horizontal or iatrogenic infection in our Clinic,
except in two patients known to have received contaminated batches, and
in one who had had regular plasma infusions. Thus, common variable
immunodeficiency (CVID) patients in England do not have a high incidence
of HCV infection despite exposure to various immunoglobulin products.
This contrasts with the recently reported high prevalence in similar
patients in Italy. Although our data reinforce the impression that both
intramuscular and current licensed i.v. preparations in the UK are safe,
manufacturers should be encouraged to PCR screen all batches of
immunoglobulin for HCV.
DE Agammaglobulinemia/PHYSIOPATHOLOGY/THERAPY Common Variable
Immunodeficiency/*EPIDEMIOLOGY/PHYSIOPATHOLOGY/ THERAPY Hepatitis
C/*EPIDEMIOLOGY/IMMUNOLOGY/PHYSIOPATHOLOGY Human Immunoglobulins,
Intravenous/ADVERSE EFFECTS Liver Function Tests Prevalence JOURNAL
ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).